Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multicenter study of atrial fibrillation].

Habiba Drissa1, Najoua Essafi, Haifa Mahjoub

  • 1Service de cardiologie Adultes, Hôpital La Rabta Tunis.

La Tunisie Medicale
|November 12, 2003
PubMed
Summary

This study on atrial fibrillation (AF) found that rheumatic carditis was the most common cause. Electrical cardioversion was more successful than pharmacological methods for AF reduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Correction: Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).

PloS one·2025
Same author

Novel Electrospun PVA-PVP-PAAm/TiO<sub>2</sub> Nanofibers with Enhanced Optoelectrical, Antioxidant and Antibacterial Performances.

Polymers·2025
Same author

Correction: Enhancing the multifunctional properties of polycaprolactone/chitosan films with zirconium dioxide nanoparticles for biomedical and flexible optoelectronic applications.

RSC advances·2025
Same author

Enhancing the multifunctional properties of polycaprolactone/chitosan films with zirconium dioxide nanoparticles for biomedical and flexible optoelectronic applications.

RSC advances·2025
Same author

New onset heart failure with reduced ejection fraction management: single center, real-life Tunisian experience.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology·2023

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is a common arrhythmia with significant morbidity and mortality.
  • Understanding the etiology and effective treatment strategies for a first episode of AF is crucial.

Purpose of the Study:

  • To analyze the characteristics, etiologies, and outcomes of patients experiencing their first episode of atrial fibrillation.
  • To compare the effectiveness of electrical versus pharmacological cardioversion for AF reduction.
  • To identify predictors of successful AF reduction.

Main Methods:

  • Retrospective analysis of 1134 patients with a first episode of atrial fibrillation (AF) from January 1985 to December 2000.
  • Data collected included patient demographics, AF etiology, treatment methods (electrical and pharmacological cardioversion), and survival rates.

Related Experiment Videos

  • Statistical analysis to compare outcomes between AF and sinus rhythm groups and to identify predictors of AF reduction success.

    • Main Results:

    • Rheumatic carditis (36.1%) and idiopathic causes (27.7%) were the leading etiologies of AF.
    • Patients with AF had significantly higher morbi-mortality and lower five-year survival (85%) compared to sinus rhythm (96%).
    • Electrical cardioversion achieved a 70% success rate, significantly higher than pharmacological cardioversion (40%).
    • Left atrial diameter did not predict AF reduction success, but longer duration of AF was associated with treatment failure.

    Conclusions:

    • First episode atrial fibrillation, particularly due to rheumatic carditis, is associated with increased mortality.
    • Electrical cardioversion is a more effective strategy for AF reduction compared to pharmacological approaches.
    • The duration of atrial fibrillation is a key factor predicting the failure of cardioversion therapies.